Timothy Hoey is CSO & VP at OncoMed Pharmaceuticals Inc (OMED). They have made 6 open-market trades across 2 companies since 2014, most recently 2024-03-05.
CIK 0001302573
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TNYA | SELL · 10b5-1 | 2024-03-05 | 2024-03-06 | $7.00 | $23K | -25.6% | -27.6% | -43.2% |
| TNYA | SELL · 10b5-1 | 2024-02-20 | 2024-02-21 | $5.34 | $35K | +24.7% | -10.9% | -21.1% |
| TNYA | SELL | 2024-02-16 | 2024-02-16 | $5.86 | $27K | -3.9% | -22.1% | -31.3% |
| TNYA | SELL · 10b5-1 | 2023-08-29 | 2023-08-29 | $4.26 | $31K | -21.3% | -37.8% | -54.1% |
| TNYA | SELL | 2023-08-16 | 2023-08-18 | $3.81 | $15K | +4.9% | -25.0% | -53.6% |
| TNYA | SELL · 10b5-1 | 2022-04-26 | 2022-04-28 | $10.13 | $14K | -22.9% | -31.1% | -51.2% |
| OMED | SELL | 2017-04-04 | 2017-04-05 | $9.06 | $104K | -55.9% | -58.7% | -59.5% |
| OMED | SELL | 2017-01-03 | 2017-01-05 | $7.64 | $195K | -6.4% | -1.1% | +3.7% |
| OMED | SELL | 2016-11-16 | 2016-11-18 | $9.89 | $124K | -15.3% | -19.7% | -10.6% |
| OMED | SELL | 2016-01-06 | 2016-01-08 | $22.28 | $96K | -18.1% | -55.5% | -47.5% |
| OMED | SELL · 10b5-1 | 2015-06-22 | 2015-06-24 | $26.07 | $130K | -32.1% | -0.5% | -0.5% |
| OMED | SELL · 10b5-1 | 2015-04-27 | 2015-04-29 | $25.65 | $177K | -32.1% | -0.5% | -0.5% |
| OMED | SELL · 10b5-1 | 2015-02-05 | 2015-02-09 | $22.83 | $171K | -32.1% | -0.5% | -0.5% |
| OMED | SELL · 10b5-1 | 2014-11-05 | 2014-11-07 | $19.51 | $49K | -32.1% | -0.5% | -0.5% |
| OMED | SELL · 10b5-1 | 2014-08-05 | 2014-08-07 | $21.67 | $54K | -32.1% | -0.5% | -0.5% |
| OMED | SELL · 10b5-1 | 2014-05-05 | 2014-05-07 | $26.41 | $66K | -32.1% | -0.5% | -0.5% |
| OMED | SELL · 10b5-1 | 2014-03-05 | 2014-03-07 | $35.81 | $64K | -32.1% | -0.5% | -0.5% |
| OMED | SELL · 10b5-1 | 2014-02-05 | 2014-02-07 | $30.10 | $151K | -32.1% | -0.5% | -0.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.